Previous Close | 9.97 |
Open | 10.06 |
Bid | 9.35 |
Ask | 10.20 |
Strike | 180.00 |
Expire Date | 2026-01-16 |
Day's Range | 10.06 - 10.06 |
Contract Range | N/A |
Volume | |
Open Interest | 322 |
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.